Episode Details
Back to Episodes
Companies To Watch: The AI biotech company everyone is watching
Published 6 months ago
Description
Insilico Medicine has just signed a deal worth up to $2.75 billion with Eli Lilly, putting the spotlight firmly on AI-driven drug discovery.
In this episode of Companies to Watch, Dan Koh and Ryan Huang break down what Insilico Medicine actually does, why its Hong Kong IPO drew massive investor demand, and what this latest partnership means for the future of healthcare.
See omnystudio.com/listener for privacy information.